PTPA and acute myeloid leukemia: In AML models, FTY720-mediated PP2A reactivation induces apoptosis and diminishes leukemic proliferation in a dose-dependent manner, with effects rescued by PP2A inhibition, indicating that the anticancer activity is PP2A-dependent [100,101].